The grocery distributor's post-earnings drubbing appears to be a big overreaction.
These consumer products names are the comeback kings of this market.
It's risky, but I like the stock's 4.3% dividend yield.
Let's check the charts again.
Matt Karnes, the founder of cannabis industry analytics firm GreenWave Advisors, said that based on his estimates of public sales and dispensary data, MedMen is outpacing the statewide average between $200,000 and $250,000 quarterly revenue per store.
Buyers rushed in after WMT reported earnings, sending it nearly 9% higher.
Keep these issues in mind as you think about how to trade right now.
Try this the out-of-the-money, bullishly biased vertical call spread on volatility in CPB.
Let's check out the charts and indicators to see what sort of upside remains.
This value stock is a healthy choice.